200,000+ products from a single source!

sales@angenechem.com

Home > Nitro Compounds > 30729-49-8

30729-49-8

30729-49-8 | Benzenesulfonic acid, dinitro- (8CI,9CI)

CAS No: 30729-49-8 Catalog No: AG003126 MDL No:

Product Description

Catalog Number:
AG003126
Chemical Name:
Benzenesulfonic acid, dinitro- (8CI,9CI)
CAS Number:
30729-49-8
Molecular Formula:
C6H4N2O7S
Molecular Weight:
248.1702
IUPAC Name:
2,3-dinitrobenzenesulfonic acid
InChI:
InChI=1S/C6H4N2O7S/c9-7(10)4-2-1-3-5(16(13,14)15)6(4)8(11)12/h1-3H,(H,13,14,15)
InChI Key:
IORISFYTXJVNFE-UHFFFAOYSA-N
SMILES:
[O-][N+](=O)c1c(cccc1S(=O)(=O)O)[N+](=O)[O-]

Properties

Complexity:
389  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
247.974g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
248.165g/mol
Monoisotopic Mass:
247.974g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
154A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.3  

Literature

Title Journal
A selective fluorescent turn-on NIR probe for cysteine. Organic & biomolecular chemistry 20120314
DNFB-DNS hapten-induced colitis in mice should not be considered a model of inflammatory bowel disease. Inflammatory bowel diseases 20111001
Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease. International immunopharmacology 20110801
Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model. Investigative radiology 20110801
Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacology & therapeutics 20110701
Dextran sulfate sodium inhibits alanine synthesis in Caco-2 cells. International journal of molecular sciences 20110101
Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa. PloS one 20110101
Role of the transient receptor potential vanilloid 1 in inflammation and sepsis. Journal of inflammation research 20110101
Protective effect of aqueous extract of Oroxylum indicum Linn. (root bark) against DNBS-induced colitis in rats. Indian journal of pharmacology 20110101
Ultraviolet irradiation of mice reduces the competency of bone marrow-derived CD11c+ cells via an indomethacin-inhibitable pathway. Journal of immunology (Baltimore, Md. : 1950) 20101215
Perinatal lipid nutrition alters early intestinal development and programs the response to experimental colitis in young adult rats. American journal of physiology. Gastrointestinal and liver physiology 20101201
UVR-induced regulatory T cells switch antigen-presenting cells from a stimulatory to a regulatory phenotype. The Journal of investigative dermatology 20100701
In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 20100401
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease. Free radical research 20100101
Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice. Journal of biomedicine & biotechnology 20100101
The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PloS one 20100101
Neuroinflammation in inflammatory bowel disease. Journal of neuroinflammation 20100101
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice. PPAR research 20100101
Molecular Characterization of the Onset and Progression of Colitis in Inoculated Interleukin-10 Gene-Deficient Mice: A Role for PPARalpha. PPAR research 20100101
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. Journal of molecular medicine (Berlin, Germany) 20091101
Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 20091101
Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 20090601
Adenosine and adenosine receptors: Newer therapeutic perspective. Indian journal of pharmacology 20090601
Peroxisome proliferator-activated receptor-alpha modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice. Shock (Augusta, Ga.) 20090301
Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis. Biochemical pharmacology 20090301
Intestinal inflammation in rats induces metallothionein in colonic submucosa. Journal of clinical biochemistry and nutrition 20090301
Magnetic resonance imaging of experimental inflammatory bowel disease: quantitative and qualitative analyses with histopathologic correlation in a rat model using the ultrasmall iron oxide SHU 555 C. Investigative radiology 20090101
Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clinical and experimental immunology 20090101
Evidence for a potential role of metallothioneins in inflammatory bowel diseases. Mediators of inflammation 20090101
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PloS one 20090101
Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB. Mediators of inflammation 20090101
Synergistic effects of chemical insult and toll-like receptor ligands on dendritic cell activation. Toxicology in vitro : an international journal published in association with BIBRA 20081201
Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. Journal of pineal research 20080901
In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027. European journal of pharmacology 20080531
Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. American journal of physiology. Gastrointestinal and liver physiology 20080401
Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus. American journal of physiology. Gastrointestinal and liver physiology 20080301
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. Journal of molecular medicine (Berlin, Germany) 20080101
Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis. International journal of medical sciences 20080101
Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Digestive diseases and sciences 20071001
CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. The American journal of pathology 20071001
Vagus nerve integrity and experimental colitis. American journal of physiology. Gastrointestinal and liver physiology 20070901
A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20070801
Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host. International journal for parasitology 20070301
Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice. Free radical biology & medicine 20070101
Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. American journal of physiology. Gastrointestinal and liver physiology 20061101
TNF-alpha is crucial for the development of mast cell-dependent colitis in mice. American journal of physiology. Gastrointestinal and liver physiology 20061101
Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. Journal of pineal research 20061101
Identification of gene expression changes induced by chemical allergens in dendritic cells: opportunities for skin sensitization testing. The Journal of investigative dermatology 20060801
CB1 and TRPV1 receptors mediate protective effects on colonic electrophysiological properties in mice. Journal of molecular medicine (Berlin, Germany) 20060601
Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis. Shock (Augusta, Ga.) 20060501
Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. Journal of immunology (Baltimore, Md. : 1950) 20060401
5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis. Shock (Augusta, Ga.) 20060401
Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD. Journal of drug targeting 20060401
Vanilloid receptor (TRPV1)-deficient mice show increased susceptibility to dinitrobenzene sulfonic acid induced colitis. Journal of molecular medicine (Berlin, Germany) 20060201
Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat. Autonomic neuroscience : basic & clinical 20060130
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respiratory research 20060101
Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, ameliorates intestinal damage in rat models of colitis and shock. European journal of pharmacology 20051219
Green tea polyphenol extract attenuates colon injury induced by experimental colitis. Free radical research 20050901
Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis. Mediators of inflammation 20050831
5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration. Laboratory investigation; a journal of technical methods and pathology 20050601
Thalidomide treatment reduces colon injury induced by experimental colitis. Shock (Augusta, Ga.) 20050601
Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. Journal of immunology (Baltimore, Md. : 1950) 20050601
Aromatic-aromatic interaction of amitriptyline: implication of overdosed drug detoxification. Journal of pharmaceutical sciences 20050201
Myenteric plexus injury and apoptosis in experimental colitis. Autonomic neuroscience : basic & clinical 20050115
Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. European journal of pharmacology 20050110
Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respiratory research 20050101
Erythropoietin reduces the development of experimental inflammatory bowel disease. The Journal of pharmacology and experimental therapeutics 20041201
Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Laboratory investigation; a journal of technical methods and pathology 20041201
5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn-Schmiedeberg's archives of pharmacology 20041201
Effects of iron deprivation or chelation on DNA damage in experimental colitis. International journal of colorectal disease 20040901
Murine model for non-IgE-mediated asthma. Inflammation 20040601
Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. Toxicology letters 20040502
TFF-2 inhibits iNOS/NO in monocytes, and nitrated protein in healing colon after colitis. Peptides 20040501
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat. Life sciences 20040416
High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis. Shock (Augusta, Ga.) 20040401
Engineered lymphocytes to treat dinitrobenzene sulphonic acid colitis in mice. European journal of gastroenterology & hepatology 20031201
Lymphocytes endowed with colon-selective homing and engineered to produce TGF-beta1 prevent the development of dinitrobenzene sulphonic acid colitis. European journal of gastroenterology & hepatology 20031201
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats. Clinical immunology (Orlando, Fla.) 20031201
Lung proteome alterations in a mouse model for nonallergic asthma. Proteomics 20031001
The tachykinin NK1 receptor is crucial for the development of non-atopic airway inflammation and hyperresponsiveness. European journal of pharmacology 20030829
Curcumin attenuates DNB-induced murine colitis. American journal of physiology. Gastrointestinal and liver physiology 20030701
Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Autonomic neuroscience : basic & clinical 20030430
The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. British journal of pharmacology 20030201
Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis. Cellular and molecular biology (Noisy-le-Grand, France) 20030201
Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20021101
Variable response to probiotics in two models of experimental colitis in rats. Inflammatory bowel diseases 20021101
Key role for mast cells in nonatopic asthma. Journal of immunology (Baltimore, Md. : 1950) 20020815
GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat. Biochemical pharmacology 20020715
Modulatory effects of estrogen in two murine models of experimental colitis. American journal of physiology. Gastrointestinal and liver physiology 20020701
Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Molecular medicine (Cambridge, Mass.) 20020701
Intestinal inflammation modulates expression of the synaptic vesicle protein neuronal calcium sensor-1. American journal of physiology. Gastrointestinal and liver physiology 20020601
Mast cell-derived TNF-alpha primes sensory nerve endings in a pulmonary hypersensitivity reaction. Journal of immunology (Baltimore, Md. : 1950) 20020515
Effect of zinc supplementation on intestinal permeability in experimental colitis. The Journal of laboratory and clinical medicine 20020501
Hypersensitivity reactions in mouse airways after a single and a repeated hapten challenge. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20020201
Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats. European journal of pharmacology 20011109
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats. Alimentary pharmacology & therapeutics 20011001
Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut 20010401
Effect of zinc supplementation on trace elements and intestinal metallothionein concentrations in experimental colitis in the rat. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010301
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. Journal of pineal research 20010101

© 2019 Angene International Limited. All rights Reserved.